YES PHARMACEUTICAL DEVELOPMENT SERVICES GMBH

Italy

All drugs from this manufacturer

  • MEVLYQ

    It is an anticancer drug used in adults for the treatment of metastatic or locally advanced breast cancer (when other therapies have not been effective) and for advanced or metastatic liposarcoma (a tumor of the fatty tissue) after the failure of a previous therapy.

    Dosage form: solution for injection

    Active substance Dosage
    eribulin -

    ATC: L01XX41